DEFA14A ·Filed Apr 22, 2026
Proxy solicitation materials
Actionable Insight • Neutral
Monitor for any shareholder activism or governance issues in future filings, but this routine proxy statement has no immediate financial impact.
Final — all horizons settled through T+60d ⚠ clustered
MBX ▲ +87.37% at T+60d
NEUTRAL call +87.37% · α vs SPY +82.59% · entry $33.58 → $62.92
T+1d
-0.57%
call -0.57% · α -0.17%
$33.39
settled 6mo ago
T+5d
-15.10%
call -15.10% · α -15.15%
$28.51
settled 6mo ago
T+20d
-9.50%
call -9.50% · α -12.67%
$30.39
settled 5mo ago
T+60d
+87.37%
call +87.37% · α +82.59%
$62.92
settled 3mo ago
Price Chart
Loading chart...
Executive Summary
MBX Biosciences is holding its 2026 annual meeting to elect two Class II directors and ratify the appointment of Ernst & Young as its independent auditor. This is a routine governance filing.
Key Financial Metrics
Vote
director election
Meeting
2026-06-04
Seats Contested
2
Key Facts
- Election of two Class II directors: Patrick J. Heron and Edward T. Mathers
- Ratification of Ernst & Young as the company's independent auditor
- Meeting date: June 4, 2026
Financial Impact
No direct financial impact
revenueepsdebtdilution
Risk Factors
- Potential for shareholder activism if governance concerns arise
- Risk of auditor independence issues
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-168543 |
| Document: 0001193125-26-168543-index-headers.html | 0001193125-26-168543 |
| Document: 0001193125-26-168543-index.html | 0001193125-26-168543 |
| Document: 0001193125-26-168543.txt | 0001193125-26-168543 |
27 reports for MBX
70% Hit rate @ T+1 Went positive at some point 8 of 10 best @ T+60▲ +85.57%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | 3 | $50.46 $48.50 | ▼ −3.88% | ▼ −3.36% | $48.50 (−3.88%) |
Oct 22, 2026 4d ago | 8-K | $50.46 $48.50 | ▼ −3.88% | ▼ −3.36% | $48.50 (−3.88%) |
Aug 27, 2026 8w ago | Press Release | $66.39 $63.00 | ▼ −5.11% | ▼ −4.88% | $48.50 (−26.95%) |
Aug 17, 2026 10w ago | 144 | $68.25 $66.52 | ▼ −2.53% | ▼ −1.86% | $48.50 (−28.94%) |
Aug 6, 2026 11w ago | 8-K | $67.11 $67.82 | ▲ +1.06% | ▲ +0.45% | $48.50 (−27.73%) |
Jun 12, 2026 19w ago | 8-K | $35.51 $38.98 | ▲ +9.77% | ▲ +8.01% | $48.50 (+36.58%) |
Jun 12, 2026 19w ago | Press Release | $35.51 $38.98 | ▲ +9.77% | ▲ +8.01% | $48.50 (+36.58%) |
Jun 11, 2026 19w ago | Institutional Cluster | $37.25 $35.51 | ▼ −4.67% | ▼ −5.21% | $48.50 (+30.20%) |
Jun 11, 2026 19w ago | Institutional Cluster | $37.25 $35.51 | ▼ −4.67% | ▼ −5.21% | $48.50 (+30.20%) |
Jun 10, 2026 19w ago | 144 | $30.99 $37.25 | ▲ +20.20% | ▲ +18.50% | $48.50 (+56.50%) |
Showing 10 of 27
US Market Status
Market Closed — Opens Wed (12h 38m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers